Short-term regression of corneal neovascularization with combination therapy of argon green laser photocoagulation and subconjunctival bevacizumab

We present a case of a 49 year-old male with history of corneal neovascularization secondary to herpes zoster keratitis that clinically and subjectively improved for approximately 4 months after treatment with argon laser photocoagulation to feeder vessels and subconjunctival bevacizumab. This is th...

Descripción completa

Detalles Bibliográficos
Autores principales: Anand, Nandita, Reidy, James J, Riaz, Kamran M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489666/
https://www.ncbi.nlm.nih.gov/pubmed/31114395
http://dx.doi.org/10.2147/IMCRJ.S195990
_version_ 1783414863383494656
author Anand, Nandita
Reidy, James J
Riaz, Kamran M
author_facet Anand, Nandita
Reidy, James J
Riaz, Kamran M
author_sort Anand, Nandita
collection PubMed
description We present a case of a 49 year-old male with history of corneal neovascularization secondary to herpes zoster keratitis that clinically and subjectively improved for approximately 4 months after treatment with argon laser photocoagulation to feeder vessels and subconjunctival bevacizumab. This is the first report in the literature that describes this novel combination treatment for corneal neovascularization in the setting of varicella-zoster virus and discusses its efficacy.
format Online
Article
Text
id pubmed-6489666
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-64896662019-05-21 Short-term regression of corneal neovascularization with combination therapy of argon green laser photocoagulation and subconjunctival bevacizumab Anand, Nandita Reidy, James J Riaz, Kamran M Int Med Case Rep J Case Report We present a case of a 49 year-old male with history of corneal neovascularization secondary to herpes zoster keratitis that clinically and subjectively improved for approximately 4 months after treatment with argon laser photocoagulation to feeder vessels and subconjunctival bevacizumab. This is the first report in the literature that describes this novel combination treatment for corneal neovascularization in the setting of varicella-zoster virus and discusses its efficacy. Dove 2019-04-11 /pmc/articles/PMC6489666/ /pubmed/31114395 http://dx.doi.org/10.2147/IMCRJ.S195990 Text en © 2019 Anand et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Case Report
Anand, Nandita
Reidy, James J
Riaz, Kamran M
Short-term regression of corneal neovascularization with combination therapy of argon green laser photocoagulation and subconjunctival bevacizumab
title Short-term regression of corneal neovascularization with combination therapy of argon green laser photocoagulation and subconjunctival bevacizumab
title_full Short-term regression of corneal neovascularization with combination therapy of argon green laser photocoagulation and subconjunctival bevacizumab
title_fullStr Short-term regression of corneal neovascularization with combination therapy of argon green laser photocoagulation and subconjunctival bevacizumab
title_full_unstemmed Short-term regression of corneal neovascularization with combination therapy of argon green laser photocoagulation and subconjunctival bevacizumab
title_short Short-term regression of corneal neovascularization with combination therapy of argon green laser photocoagulation and subconjunctival bevacizumab
title_sort short-term regression of corneal neovascularization with combination therapy of argon green laser photocoagulation and subconjunctival bevacizumab
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489666/
https://www.ncbi.nlm.nih.gov/pubmed/31114395
http://dx.doi.org/10.2147/IMCRJ.S195990
work_keys_str_mv AT anandnandita shorttermregressionofcornealneovascularizationwithcombinationtherapyofargongreenlaserphotocoagulationandsubconjunctivalbevacizumab
AT reidyjamesj shorttermregressionofcornealneovascularizationwithcombinationtherapyofargongreenlaserphotocoagulationandsubconjunctivalbevacizumab
AT riazkamranm shorttermregressionofcornealneovascularizationwithcombinationtherapyofargongreenlaserphotocoagulationandsubconjunctivalbevacizumab

Ejemplares similares